119 related articles for article (PubMed ID: 3754976)
1. Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
Specht L; Nissen NI
Scand J Haematol; 1986 Apr; 36(4):367-75. PubMed ID: 3754976
[TBL] [Abstract][Full Text] [Related]
2. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
Fuller LM; Hagemeister FB; North LB; McLaughlin P; Velasquez WS; Cabanillas F
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):683-92. PubMed ID: 3280532
[TBL] [Abstract][Full Text] [Related]
3. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
[TBL] [Abstract][Full Text] [Related]
4. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
5. Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
Cancer; 1988 Apr; 61(8):1719-27. PubMed ID: 3349432
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
7. MOPP chemotherapy plus irradiation for Hodgkin's disease, stages IA to IIIB. Long-term results of the prospective trial H72 (1972-1976, 334 patients).
Andrieu JM; Dana M; Desprez-Curely JP; Jacquillat C; Weil M
Hematol Oncol; 1985; 3(4):219-31. PubMed ID: 3841333
[TBL] [Abstract][Full Text] [Related]
8. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
Specht L; Nissen NI; Walbom-Jørgensen S
Scand J Haematol; 1985 Aug; 35(2):166-73. PubMed ID: 3840275
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Mazza P; Lauria F; Sciascia R; Emiliani E; Fiacchini M; Baccarani M; Frezza G; Dominici G; Cantore M; Faedi M
Scand J Haematol; 1983 Oct; 31(4):315-21. PubMed ID: 6688679
[TBL] [Abstract][Full Text] [Related]
11. Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Fuller LM; Hagemeister FB
Recent Results Cancer Res; 1989; 117():197-204. PubMed ID: 2602645
[No Abstract] [Full Text] [Related]
12. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
13. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Hodgson DC; Tsang RW; Pintilie M; Sun A; Wells W; Crump M; Gospodarowicz MK
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1374-81. PubMed ID: 14630276
[TBL] [Abstract][Full Text] [Related]
14. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
[TBL] [Abstract][Full Text] [Related]
15. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
[TBL] [Abstract][Full Text] [Related]
16. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
[TBL] [Abstract][Full Text] [Related]
17. Combined modality (ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement.
Anselmo AP; Bove M; Cartoni C; Damico C; Maurizi Enrici R; Falchetto Osti M; Biagini C
Haematologica; 1992; 77(2):177-9. PubMed ID: 1383107
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Cramer P; Andrieu JM
J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
Bonadonna G; Valagussa P; Santoro A
Cancer Surv; 1985; 4(2):439-58. PubMed ID: 2430700
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease.
Nissen NI; Nordentoft AM
Cancer Treat Rep; 1982 Apr; 66(4):799-803. PubMed ID: 7074650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
